معرفی
Tim Eijgenraam, MSc is a researcher at the University of Groningen's University Medical Center Groningen (UMCG), Department of Cardiology. His research focuses on molecular mechanisms underlying cardiomyopathy and heart failure, with particular expertise in phospholamban-related cardiac disorders and bile acid metabolism in cardiovascular contexts.
His research interests span several interconnected domains in cardiovascular science:
- Investigation of molecular pathways in cardiomyopathy, particularly focusing on phospholamban mutations
- Exploration of bile acid metabolism and its impact on cardiac function and inflammation
- Development and analysis of mouse models for cardiac diseases
- Multi-omics approaches to identify prognostic biomarkers in heart failure
- Cardiometabolic interactions, particularly between adiposity measures and cardiovascular outcomes
Analysis of his recent publications reveals a strong focus on translational cardiac research using genetically modified mouse models. His work bridges molecular cardiology with metabolic pathways, particularly examining how bile acid composition affects cardiac function and atherosclerosis development. A significant portion of his research addresses the PLN-R14del mutation associated with arrhythmogenic cardiomyopathy, exploring potential therapeutic approaches including DWORF overexpression.
While no specific awards are listed in the available information, his research contributes to UN Sustainable Development Goals related to good health and well-being. His collaborative work spans multiple research groups within UMCG and with international partners, as evidenced by the diverse authorship on his publications.